Table 2 Multivariable analysis of continuous GNRI vs. poor prognosis.
Outcome | Overall population | |
---|---|---|
HR (95% CI) | P Value | |
All-cause deatha | ||
GNRI | 0.967 (0.932–1.003) | 0.070 |
Age, years | 1.036 (1.014–1.059) | 0.002 |
Prior arrhythmia, n (%) | 1.046 (0.657–1.665) | 0.850 |
NYHA, n (%) | 1.212 (0.951–1.546) | 0.120 |
Cholinesterase, U/L | 1.060 (0.922–1.218) | 0.411 |
BNP, pg/mL | 1.000 (1.000–1.001) | 0.005 |
Beta-blocker, n (%) | 0.574 (0.364–0.905) | 0.017 |
TPD, % | 1.003 (0.990–1.016) | 0.679 |
LVEF, % | 0.946 (0.917–0.976) | 0.001 |
Cardiac deathb | ||
GNRI | 0.950 (0.914–0.987) | 0.009 |
Age, years | 1.034 (1.010–1.060) | 0.006 |
NYHA, n (%) | 1.261 (0.964–1.648) | 0.09 |
Cholinesterase, U/L | 1.098 (0.945–1.277) | 0.223 |
BNP, pg/mL | 1.000 (1.000–1.000) | 0.229 |
Beta-blocker, n (%) | 0.560 (0.341–0.920) | 0.022 |
TPD, % | 1.002 (0.988–1.016) | 0.803 |
LVEF, % | 0.928 (0.894–0.960) | < 0.001 |